• Sign up
  • Login

Scheme Profile

Tata Nifty MidSmall Healthcare Index Fund-Reg (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
164
Inception Date
26-04-2024
Category
Other - Index Fund

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 13.9212 (15-May-2026) / 11.8744 (23-Mar-2026)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 13.92 ( 0.02) ( 0.11 %)
  • Benchmark
  • Nifty MidSmall Healthcare Index (TRI)
  • Fund Manager
  • Nitin Sharma
  • Value of () 1,00,000 since inception
  • 1,39,212
  • Entry Load
  • Nil
  • Exit Load
  • 0.25% of the applicable NAV, if redeemed on or before 15 days from the date of allotment. Nil - if redeemed on or after 15 days from the date of allotment
  • Expense Ratio (%)
  • 1.06
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 43.93 times
  • Portfolio P/B
  • 6.45 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 36.02

Risk Factors

  • Jenson's Alpha
  • 9.66
  • Standard Deviation
  • 5.11
  • Beta
  • 0.72
  • Sharpe
  • 0.23
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.00

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • Nifty MidSmall Healthcare Index (TRI)
  • 9.56
  • 12.62
  • 7.64
  • 15.35
  • 12.70
  • -

Company Top 5 Holdings

  [ As on 30 Apr 2026 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Lupin Ltd
  • Equity
  • 70,198
  • 9.88
  • Fortis Healthcare Ltd
  • Equity
  • 1,50,830
  • 8.50
  • Laurus Labs Ltd
  • Equity
  • 1,12,612
  • 7.57
  • Aurobindo Pharma Ltd
  • Equity
  • 80,906
  • 6.86
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 43,579
  • 6.40

Sector Top 5 Holdings

  [ As on 30 Apr 2026 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 10,57,139
  • 77.17
  • Healthcare
  • 4,28,615
  • 22.83

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 9.24 -2.64 9.56 -11.68 163.78
2025 -2.08 5.64 -1.31 8.55 158.82
2024 29.49 9.89 31.69 8.12 131.97

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2026 -5.07 -9.54 -4.88 -15.54 152.59
Dec-2025 0.32 3.17 0.56 5.23 158.82
Sep-2025 -0.61 -2.45 -0.50 -4.10 156.59
Jun-2025 8.26 13.01 8.50 9.97 147.99

Peer Comparison

<< < 123456> >> 

Asset Allocation

Sector Allocation

Quick links

Close